APA Corporation (APA)
NASDAQ: APA · Real-Time Price · USD
18.46
-0.83 (-4.30%)
At close: Aug 1, 2025, 4:00 PM
18.56
+0.10 (0.54%)
After-hours: Aug 1, 2025, 7:59 PM EDT
Theseus Pharmaceuticals Stock Forecast
Stock Price Forecast
The 16 analysts that cover Theseus Pharmaceuticals stock have a consensus rating of "Hold" and an average price target of $23.44, which forecasts a 26.98% increase in the stock price over the next year. The lowest target is $18 and the highest is $33.
Price Target: $23.44 (+26.98%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Theseus Pharmaceuticals stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 1 | 1 | 1 | 1 |
| Buy | 2 | 3 | 3 | 3 | 3 | 2 |
| Hold | 10 | 10 | 10 | 10 | 10 | 10 |
| Sell | 3 | 3 | 3 | 3 | 2 | 2 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 19 | 19 | 18 | 18 | 17 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Buy Reiterates $25 → $26 | Buy | Reiterates | $25 → $26 | +40.85% | Jul 22, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $21 → $20 | Hold | Maintains | $21 → $20 | +8.34% | Jul 18, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $19 → $21 | Hold | Maintains | $19 → $21 | +13.76% | Jul 17, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $24 → $22 | Hold | Maintains | $24 → $22 | +19.18% | Jul 14, 2025 |
| UBS | UBS | Hold Maintains $18 → $19 | Hold | Maintains | $18 → $19 | +2.93% | Jul 14, 2025 |
Financial Forecast
Revenue This Year
9.06B
from 9.47B
Decreased by -4.33%
Revenue Next Year
8.40B
from 9.06B
Decreased by -7.33%
EPS This Year
3.03
from 2.27
Increased by 33.52%
EPS Next Year
2.92
from 3.03
Decreased by -3.71%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.1B | 9.7B | 10.3B | ||
| Avg | 9.1B | 8.4B | 9.0B | ||
| Low | 8.0B | 6.8B | 8.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.9% | 6.6% | 22.9% | ||
| Avg | -4.3% | -7.3% | 7.2% | ||
| Low | -15.3% | -25.0% | -5.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.72 | 6.26 | 6.86 | ||
| Avg | 3.03 | 2.92 | 3.50 | ||
| Low | 1.76 | 1.18 | 1.05 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 107.8% | 106.5% | 134.9% | ||
| Avg | 33.5% | -3.7% | 20.1% | ||
| Low | -22.3% | -61.1% | -64.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.